⌘K

Login Start Free

Home/Filings/4/0001415889-25-004530

4//SEC Filing

Noble James 4

Accession 0001415889-25-004530

CIK 0001840748other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 8:15 PM ET

Size

5.5 KB

Accession

0001415889-25-004530

Insider Transaction Report

Form 4

Period: 2025-02-13

LAVA Therapeutics NVLVTX

Director

Transactions

Award
Common Shares (Right to Buy)
2025-02-13+33,390→ 33,390 total
Exercise: $0.93Exp: 2035-02-12→ Common Shares (33,390 underlying)

Footnotes (1)

[F1]100% of the shares underlying the option will vest on February 13, 2026, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting date.

Documents

1 file

4
form4-02182025_080216.xmlPrimary

Issuer

LAVA Therapeutics NV

CIK 0001840748

Entity typeother

Related Parties

1

filerCIK 0001388000

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 8:15 PM ET
Size: 5.5 KB

View on SEC.gov